Empagliflozin and linagliptin and Noxafil (Posaconazole Delayed-Release Tablets)
Determining the interaction of Empagliflozin and linagliptin and Noxafil (Posaconazole Delayed-Release Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: posaconazole
Brand name: Noxafil
Synonyms: Noxafil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-Noxafil (Posaconazole Injection)
- Empagliflozin and linagliptin-Noxafil (Posaconazole Oral Suspension)
- Empagliflozin and linagliptin-Noxafil Intravenous
- Empagliflozin and linagliptin-Noxifol-D
- Empagliflozin and linagliptin-Noxivent
- Empagliflozin and linagliptin-NP Thyroid
- Noxafil (Posaconazole Delayed-Release Tablets)-Empagliflozin and metformin
- Noxafil (Posaconazole Delayed-Release Tablets)-Empagliflozin and Metformin Extended-Release Tablets
- Noxafil (Posaconazole Delayed-Release Tablets)-Empagliflozin and Metformin Tablets
- Noxafil (Posaconazole Delayed-Release Tablets)-Empliciti
- Noxafil (Posaconazole Delayed-Release Tablets)-Emsam
- Noxafil (Posaconazole Delayed-Release Tablets)-Emsam Transdermal